A study demonstrated that a class of tumor-associated macrophages (SPP1 hi-TAMs), which highly express SPP1 and secrete adenosine to activate the A2AR signaling pathway, emerged in metastatic desmoplasia-resistant prostate cancer, leading to ICIs resistance in vivo (129). The gene discussed is SPP1; the disease is prostate carcinoma.